Reports for MANTRA PHARMA INC
Company Name
MANTRA PHARMA INC
Totals |
||
Shortage reports |
54 |
|
| Actual shortage: | 16 (30%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 38 (70%) | |
Discontinuation Reports |
8 |
|
| To be discontinued: | 1 (13%) | |
| Discontinued: | 7 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
43 (69%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| M-BETAHISTINE | 16MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225585 |
| M-BETAHISTINE | 8MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225577 |
| M-SOLIFENACIN SUCCINATE | 10MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225571 |
| M-SOLIFENACIN SUCCINATE | 5MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225565 |
| M-PRAVASTATIN | 40MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225556 |
| M-PRAVASTATIN | 20MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225548 |
| M-PERINDOPRIL ERBUMINE | 8MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225542 |
| M-LEVETIRACETAM | 750MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225536 |
| M-LEVETIRACETAM | 500MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225527 |
| M-ESCITALOPRAM | 20MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225524 |
| M-ESCITALOPRAM | 20MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225521 |
| M-ESCITALOPRAM | 10MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225518 |
| M-ESCITALOPRAM | 10MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225515 |
| M-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-04-18 | 2024-04-18 | 225510 |
| M-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-20 | 2023-12-04 | 185133 |
| M-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-02-20 | 2023-03-06 | 185130 |
| M-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-01-20 | 2023-12-04 | 182171 |
| M-BETAHISTINE | 16MG | TABLET | Resolved | 2023-01-20 | 2023-03-06 | 182169 |
| M-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-11-18 | 2023-03-06 | 175303 |
| M-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-07-22 | 2022-07-29 | 165372 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| M-RANITIDINE | 150MG | TABLET | Discontinued | 2020-09-17 | 2020-09-17 | 124442 |
| M-RANITIDINE | 300MG | TABLET | Discontinued | 2020-09-17 | 2020-09-17 | 124425 |
| M-EZETIMIBE | 10MG | TABLET | Discontinued | 2020-04-06 | 2020-04-08 | 111090 |
| M-ESCITALOPRAM | 20MG | TABLET | To be discontinued | 2020-03-18 | 2020-09-11 | 108922 |
| M-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2020-03-18 | 2020-03-18 | 108917 |
| M-EZETIMIBE | 10MG | TABLET | Discontinued | 2020-03-18 | 2020-04-08 | 108914 |
| M-ZOPICLONE | 3.75MG | TABLET | Discontinued | 2020-03-18 | 2020-03-18 | 108911 |
| M-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-03-18 | 2020-03-18 | 108908 |
Showing 1 to 8 of 8